Please log in to determine if you are eligible to purchase PT Programs.
MYELOID MALIGNANCIES, DOUBLE VOLUME - MHO3
MHO3
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Procedure/Gene Challenges per Shipment Number of Shipments
Myeloid Malignancy Genotyping Two shipments per year
BCR::ABL1 p190 3
BCR::ABL1 p210 3
CALR 3
CBFB::MYH11 3
FLT3 ITD 3
FLT3 TKD 3
JAK2 c.1849G>T(p.V617F) 3
KMT2A-PTD (MLL-PTD) 3
MPL 3
NPM1 3
PML::RARA 3
RUNX1::RUNX1T1 3

Program Information

  • Four sample vials; two with purified DNA containing 200 μg/mL and two with purified RNA, containing 400 μg/mL
  • Ships on dry ice

Shipping Schedule

  • Shipment A: April 18
  • Shipment B: October 17






Customers Who Bought This Item Also Bought
CAP/NSH HISTOQIP MISMATCH REPAIR IHC
VIEW DETAILS >